News
Significant’ weight returned weeks after stopping drug, say researchers who advise patients to adjust expectations.
Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 ...
Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis published in BMC Medicine.
What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global ...
Scientists found that obesity may exist in 11 biological forms, each linked to different genes and body functions.
Polycystic ovary syndrome can be difficult to diagnose, but in some cases the disorder can help explain problems with obesity ...
14don MSNOpinion
To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...
6d
GlobalData on MSNHengrui and Kailera report positive data from Phase III obesity treatment trialHengrui Pharma and Kailera Therapeutics have reported positive topline data from the former’s Phase III trial (HRS9531-301) ...
1dOpinion
The Star on MSNDR NELLY: Kenya’s quiet shift in diabetes and obesity treatmentKenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 ...
The MC4R agonist targets rare genetic and hypothalamic obesity, with potential as a combination or maintenance therapy for general obesity alongside GLP-1 agents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results